ID

31585

Beskrivning

Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00715104

Länk

https://clinicaltrials.gov/show/NCT00715104

Nyckelord

Versioner (1)
  1. 2018-09-08 2018-09-08 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

8 september 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Prostate Cancer NCT00715104

Engelsk

Eligibility Prostate Cancer NCT00715104

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
adenocarcinoma of the prostate.
Beskrivning

Adenocarcinoma of prostate

Datatyp

boolean

Alias
UMLS CUI [1]
C0007112
subject is scheduled for rp as the initial therapy for localized prostate cancer.
Beskrivning

Radical prostatectomy Scheduled | Induction Therapy Prostate carcinoma Localized

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0194810
UMLS CUI [1,2]
C0205539
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C0600139
UMLS CUI [2,3]
C0392752
subject is ≥ 18 years of age.
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
subject has an eastern cooperative oncology group (ecog) performance status of 0 or 1.
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
subject has adequate hematologic, renal, and liver function.
Beskrivning

Hematologic function | Renal function | Liver function

Datatyp

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject has any evidence of metastasis.
Beskrivning

Neoplasm Metastasis

Datatyp

boolean

Alias
UMLS CUI [1]
C0027627
subject received hormones, including luteinizing hormone-releasing hormone agonists, antiandrogens, or 5 α-reductase inhibitors at any time prior to study screening.
Beskrivning

Hormones | Luteinizing Hormone-releasing Hormone Agonist | Androgen Antagonists | 5-alpha Reductase Inhibitors

Datatyp

boolean

Alias
UMLS CUI [1]
C0019932
UMLS CUI [2]
C1518041
UMLS CUI [3]
C0002842
UMLS CUI [4]
C2936788
subject has received prior radiation therapy or chemotherapy for prostate cancer.
Beskrivning

Prior radiation therapy Prostate carcinoma | Prior Chemotherapy Prostate carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C1514457
UMLS CUI [2,2]
C0600139
subject has received systemic steroid therapy within 14 days.
Beskrivning

Steroid therapy Systemic

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0149783
UMLS CUI [1,2]
C0205373
subject has a history of stage iii or greater cancer, excluding prostate cancer.
Beskrivning

Malignant Neoplasms TNM clinical staging | Exception Prostate carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0600139
subjects with a history of basal or squamous cell skin cancers are allowed, provided that the subject was adequately treated and is disease-free at the time of study screening.
Beskrivning

Basal cell carcinoma Treated allowed | Squamous cell carcinoma of skin Treated allowed | Relationship Disease Free of

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0007117
UMLS CUI [1,2]
C1522326
UMLS CUI [1,3]
C0683607
UMLS CUI [2,1]
C0553723
UMLS CUI [2,2]
C1522326
UMLS CUI [2,3]
C0683607
UMLS CUI [3,1]
C0439849
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C0332296
subjects with a history of stage i or ii cancer must have been adequately treated and been disease-free for ≥ 3 years prior to study screening.
Beskrivning

Malignant Neoplasms Treated TNM clinical staging | Malignant Neoplasms Disease Free of

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1522326
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C0332296
Tillbaka till toppen

Similar models

Eligibility Prostate Cancer NCT00715104

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
adenocarcinoma of the prostate.
boolean
C0007112 (UMLS CUI [1])
Radical prostatectomy Scheduled | Induction Therapy Prostate carcinoma Localized
Item
subject is scheduled for rp as the initial therapy for localized prostate cancer.
boolean
C0194810 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
C0600558 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C0392752 (UMLS CUI [2,3])
Age
Item
subject is ≥ 18 years of age.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
subject has an eastern cooperative oncology group (ecog) performance status of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Hematologic function | Renal function | Liver function
Item
subject has adequate hematologic, renal, and liver function.
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Neoplasm Metastasis
Item
subject has any evidence of metastasis.
boolean
C0027627 (UMLS CUI [1])
Hormones | Luteinizing Hormone-releasing Hormone Agonist | Androgen Antagonists | 5-alpha Reductase Inhibitors
Item
subject received hormones, including luteinizing hormone-releasing hormone agonists, antiandrogens, or 5 α-reductase inhibitors at any time prior to study screening.
boolean
C0019932 (UMLS CUI [1])
C1518041 (UMLS CUI [2])
C0002842 (UMLS CUI [3])
C2936788 (UMLS CUI [4])
Prior radiation therapy Prostate carcinoma | Prior Chemotherapy Prostate carcinoma
Item
subject has received prior radiation therapy or chemotherapy for prostate cancer.
boolean
C0279134 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C1514457 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
Steroid therapy Systemic
Item
subject has received systemic steroid therapy within 14 days.
boolean
C0149783 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
Malignant Neoplasms TNM clinical staging | Exception Prostate carcinoma
Item
subject has a history of stage iii or greater cancer, excluding prostate cancer.
boolean
C0006826 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
Basal cell carcinoma Treated allowed | Squamous cell carcinoma of skin Treated allowed | Relationship Disease Free of
Item
subjects with a history of basal or squamous cell skin cancers are allowed, provided that the subject was adequately treated and is disease-free at the time of study screening.
boolean
C0007117 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C0683607 (UMLS CUI [1,3])
C0553723 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0683607 (UMLS CUI [2,3])
C0439849 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0332296 (UMLS CUI [3,3])
Malignant Neoplasms Treated TNM clinical staging | Malignant Neoplasms Disease Free of
Item
subjects with a history of stage i or ii cancer must have been adequately treated and been disease-free for ≥ 3 years prior to study screening.
boolean
C0006826 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial